The global pharmaceutical packaging market is expected to grow at noteworthy CAGR around 7.9 % throughout the forecast period and reach around US$ 112 billion by 2026.
Pharmaceutical packaging means pharmaceutical process packaging, where several of the raw materials, like glass, plastic resins, etc., are used to make pharmaceutical packaging. Because of sophisticated and diversified pharmaceutical industries, the developing economies will demand the world. The oral sector can lead the pharmaceutical packaging industry in future, based on drug delivery. Oral medicines are commonly used for mouth-wide administration of drugs, which is a simple and effective way of administering drugs.
The report provides analysis of global Pharmaceutical Packaging market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
The pharmaceutical industry offers great opportunities for development for emerging economies as China, India, and Brazil. These economies have an enormous pharmaceutical packaging market potential. Increased life expectancy attempts and higher disposable income are also anticipated to offer appealing growth possibilities as firms struggle to stagnate mature markets, expire patents and increase regulating barriers.
In particular, a flux was observed along the way to establishment of their health infrastructure in the aforementioned countries. Thus it is not possible for emerging markets to adopt a one-size-fit strategy. There are also local peculiarities that make specific solutions to these markets critical among the primary clusters of markets, namely the economies of BRICMT, India, Mexico, Brazil, Russia, and
Turkey, and the second-level nations in Southeast Asia, and Africa.
In 2018, the US represented more than 85% of the North American market. The nation is also the world's biggest drug market. The country's big healthcare system, elevated per capita incomes and big drug development investment are forecast to boost the growth of the country's pharmaceutical packaging industry.
In latest times, uncertainty regarding the US government which has given big pharmaceutical clients a comparatively strong reluctance to place orders led to a decline in the country's pharmaceutical industry. However, increasing significance of generic medicines and access to improved health facilities in the economy is expected to provide market development possibilities.
Many plastic vial companies such as Amcor Ltd. Inc., Gerresheimer AG; and Berry Plastics Group, are likely to present in the nation over the projected era, with a beneficial effect on plastic vial demand in their sector. Demand for plastics and polymers will probably advance over the forecast era at a CAGR of 9.1 percent.
The increasing worldwide demand for appropriate packaging products is expected to be met by the growing pharmaceutical industry. Various plastics and polymers are widely utilized for the manufacturing of packaging alternatives such as high density polyethylene, polyester, low-density polyethylene and polyvinyl chloride.
In the packaging industry, polypropylene (PP) is being used progressively as a variant of plastics and polymers. PP is regarded a cost-effective material because it provides a mixture of mechanical, physical, electrical and temperature properties not found in a thermoplasty of any kind. PP shows a greater operating temperature and tensile strength relative to elevated and low-density polyethylene. In corrosive settings, it also provides adequate chemical resistance. It also offers resistance to degreasers, organic solvents and electrolytic attacks. It is a lightweight material with a low absorption rate of humidity and is stain-resistant.
The main segment represented the biggest market share of over 70% in 2018. Over the forecast era it is anticipated to maintain its pole position.
In terms of the use in bulk and prescription dose packs (oral ethical drug) and large-scale packaging of solid-dose oral over - the-counter medicines, Plastic bottle / part of the primary segment is estimated to be highly consumable during the projected period. Due to the adaptable unit dose and clinical trial dosage formats with extended label material, high visibility and integrated track and trace characteristics Blister packing is one of the most common main alternatives in this field.
The secondary segment comprises all procedures including the packaging or packaging of main products for grouping purposes. In the coming years, the secondary industry is anticipated to grow in the context of the increasing demand for products that will offer advantages such as leakage avoidance, diffusion and product penetration.
End Use Insights
In the pharmaceutical industry, the leading market share in 2018 was over 35%. During the forecast period, the segment is anticipated to remain prominent.
The growing population and the growing demand for better healthcare services are anticipated to have a beneficial effect over the forecast era on the development of the pharmaceutical sector. Moreover, growing public assistance for this industry's growth in emerging countries is likely to increase packaging demand in the coming years.
Manufacturers prefer outsourcing to third-party suppliers of packing operations that can drive demand for packaging on contract. The outsourcing of packaging operations has been improved to save time and costs for market players in the pharmaceutical industry. Pharmaceutical companies outsource employment to dedicated and competent contractors instead of investing in their products ' packaging. The demand for the contract segment will be driven by these variables over a prediction period.
Rapid financial growth has led to enhanced prosperity and government health, with the increase in the demand for pharmaceuticals in Brazil, China, Mexico, Russia, India, and Turkey. The trend in the manufacture, which in turn increases their demand, has decreased the cost of pharmaceutical goods. During the prediction era, these variables can favorably influence business development.
The highest market share for North America in 2018 exceeded 35 percent. The increase in the production of child resistant packaging products is one of the variables contributing to this. In addition, the growing manufacture of branded medicines which require more input of packaging components to safeguard the medicine against the outside setting supports regional product demand. In addition, national development was facilitated by the existence of leading producers of branded medicines, including Johnson & Johnson; Merck (Schering-Plough Canada Inc.); Pfizer; Sanofi-Aventis (Sanofi Pasteur); and GlaxoSmithKline Inc.
Asia Pacific is projected to grow by about 12% during the prediction era at the highest CAGR. The expected development is due to the growing popularity of rigid plastics. Increasing demand is expected in the national industry for polyethylene terephthalate (PET) and polyethylene (PPE) as main plastics used in the product production. The development of the regional economy has been enhanced by a rise in public regulations on drug safety. In order for drugs to be secure from external environmental variables, the use of pharmaceutical packaging is crucial and vice versa in some instances.
Global Pharmaceutical Packaging Market, By Material
Global Pharmaceutical Packaging Market, By Product
Global Pharmaceutical Packaging Market, By End Use
Global Pharmaceutical Packaging Market, By Geography
The market research study on “Pharmaceutical Packaging Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Pharmaceutical Packaging market segments with market dynamics and their impact. The report also covers basic technology development policies.
The study offers an assessment of the most recent developments in each sub-segment, from 2014 to 2026 and forecasts income development at the worldwide, regional and nation levels. ARC has divided the international market report for pharmaceutical packaging based on content, product, End use and area for the purpose of this research.
Key Players & Strategies
Major market players are Gerresheimer AG; West Pharmaceutical Service Inc.; Amcor Ltd.; Schott AG; BD; and Aptar Group. The market is highly fragmented with several players operating at both local and regional levels. Other prominent players are Owens Illinois Inc.; Bemis Company; Capsugel; Berry Global; COMAR LLC; SGD SA; and International Paper Company.
Competition is anticipated to improve with the diversification approach to provide information services together with the existing product portfolio. The manufacture of high-value products from materials such as bioplastics and recyclable paper should assist businesses to differentiate products.
Fusions and acquisitions were found to be a main strategic to resist competition in the industry by important players. Companies are seeking product management in certain categories because of the anticipated rise in combination assessments during the forecast period. In order to address lucrative company segments, industry participants are engaged in a reorganization. Companies try to strike a balance between investing in and keeping price levels, with growing emphasis on sustainable packaging.